You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023156018
Dec 20233607
Jan 20241702
Feb 20241803
Mar 20241804
Apr 20241005
May 20242404
Jun 20242201
Jul 2024803
Aug 20241001
Sep 20241601
Oct 20241205
Nov 20241805
Dec 20241606
Jan 20251607
Feb 2025707
Mar 2025006
Apr 2025001
May 2025006
Jun 2025003
Total404095